financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Chemours Appoints Interim CEO Denise Dignam as Chief Executive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chemours Appoints Interim CEO Denise Dignam as Chief Executive
Mar 22, 2024 2:37 PM

05:02 PM EDT, 03/22/2024 (MT Newswires) -- Chemours ( CC ) said late Friday it has appointed Denise Dignam, current interim CEO, to the positions of presidentand chief executive officer and a board member, effective immediately.

The firm also said Matthew Abbott will remain as interim chief financial officer while a search has begun for a permanent CFO.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US judge delays launch of sports streaming venture from Disney, media giants
US judge delays launch of sports streaming venture from Disney, media giants
Aug 16, 2024
Aug 16 (Reuters) - A federal judge on Friday temporarily blocked the launch of a new sports streaming service backed by three major media companies, Walt Disney ( DIS ), Fox and Warner Bros Discovery ( WBD ), who aim to capture sports fans not watching games on television. The ruling is a blow for Disney ( DIS ), Fox...
 Akamai Technologies Insider Sold Shares Worth $251,725, According to a Recent SEC Filing
Akamai Technologies Insider Sold Shares Worth $251,725, According to a Recent SEC Filing
Aug 16, 2024
05:11 PM EDT, 08/16/2024 (MT Newswires) -- Robert Blumofe, Chief Technology Officer, on August 16, 2024, sold 2,500 shares in Akamai Technologies ( AKAM ) for $251,725. Following the Form 4 filing with the SEC, Blumofe has control over a total of 22,010 shares of the company, with 22,010 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1086222/000108622224000201/xslF345X03/wk-form4_1723842035.xml Price: 100.49, Change: -0.01, Percent...
 Neurocrine Biosciences Insider Sold Shares Worth $2,090,333, According to a Recent SEC Filing
Neurocrine Biosciences Insider Sold Shares Worth $2,090,333, According to a Recent SEC Filing
Aug 16, 2024
05:11 PM EDT, 08/16/2024 (MT Newswires) -- William H Rastetter, Director, on August 15, 2024, sold 14,250 shares in Neurocrine Biosciences ( NBIX ) for $2,090,333. Following the Form 4 filing with the SEC, Rastetter has control over a total of 37,491 shares of the company, with 37,491 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/914475/000091447524000197/xslF345X03/wk-form4_1723842044.xml Price: 146.50, Change: +1.49, Percent Change:...
 Magnite Insider Sold Shares Worth $947,250, According to a Recent SEC Filing
Magnite Insider Sold Shares Worth $947,250, According to a Recent SEC Filing
Aug 16, 2024
05:17 PM EDT, 08/16/2024 (MT Newswires) -- Michael G. Barrett, Director, CEO, on August 15, 2024, sold 75,000 shares in Magnite ( MGNI ) for $947,250. Following the Form 4 filing with the SEC, Barrett has control over a total of 944,552 shares of the company, with 944,552 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1595974/000141588924021484/xslF345X03/form4-08162024_090802.xml Price: 12.69, Change: +0.15, Percent Change:...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved